Review
Copyright ©2012 Baishideng. All rights reserved.
World J Virol. Dec 12, 2012; 1(6): 162-173
Published online Dec 12, 2012. doi: 10.5501/wjv.v1.i6.162
Hepatitis viruses and non-Hodgkin’s lymphoma: A review
Sibnarayan Datta, Soumya Chatterjee, Rudragoud S Policegoudra, Hemant K Gogoi, Lokendra Singh
Sibnarayan Datta, Soumya Chatterjee, Rudragoud S Policegoudra, Hemant K Gogoi, Lokendra Singh, Biotechnology Division, Defence Research Laboratory, Tezpur, Assam, PIN-784001, India
Author contributions: Datta S and Chatterjee S conceptualized and drafted the manuscript; Policegoudra RS, Gogoi HK and Singh L edited and revised the manuscript.
Correspondence to: Sibnarayan Datta, PhD, Biotechnology Division, Defence Research Laboratory, Post bag No. 2, Tezpur, Assam, PIN-784001, India. sndatta1978@gmail.com
Telephone: +91-3712-258508 Fax: +91-3712-258534
Received: October 9, 2011
Revised: June 6, 2012
Accepted: November 7, 2012
Published online: December 12, 2012
Abstract

Non-Hodgkin’s lymphoma (NHL) is among the haematological malignancies with high prevalence worldwide, causing estimated 355 900 new cases and 191 400 deaths in 2008. High prevalence of NHL is documented in economically more developed areas while low prevalence is observed in less developed areas of the globe. A wide array of environmental factors have been reported to be either directly involved or in modifying the risk of NHL development. In addition to these factors, a number of infectious agents, chiefly viruses have also been implicated in the development of NHL. This article reviews the available literature to discuss the role of hepatitis viruses in NHL development, possible mechanisms of lymphomagenesis and also identify the areas in which further research is required to better understand this disease. A brief discussion on the clinical aspects such as classification, staging, treatment approaches have also been included in this article.

Keywords: Non-Hodgkin’s lymphoma; Hepatitis B virus; Hepatitis C virus; Hepatitis G virus; MiRNA